Open AccessAllosteric enhancement of the BCR-Abl1 kinase inhibition activity of nilotinib by cobinding of asciminib
Author(s) -
Baswanth Oruganti,
Erik Lindahl,
Jingmei Yang,
Wahid Amiri,
Rezwan Rahimullah,
Ran Friedman
Publication year - 2022
Publication title -
journal of biological chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.361
H-Index - 513
eISSN - 1067-8816
pISSN - 0021-9258
DOI - 10.1016/j.jbc.2022.102238
Subject(s) - nilotinib , allosteric regulation , chemistry , pharmacology , cancer research , tyrosine kinase , medicine , biochemistry , enzyme , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom